Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1994-8-12
|
pubmed:abstractText |
These studies have examined the effects of the selective neurokinin1 (NK1) receptor antagonist CP-99,994 on the retching and vomiting response to apomorphine. CP-99,994 (1-3 mg/kg i.p.) attenuated retching and vomiting induced by apomorphine (0.25 mg/kg s.c.) with complete inhibition of retching and vomiting at the 3 mg/kg dose. In contrast CP-100,263 (3 mg/kg i.p.), the enantiomer of CP-99,994 with 1000-fold lower affinity for the NK1 receptor, was without effect.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0028-3908
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
259-60
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8035913-Animals,
pubmed-meshheading:8035913-Apomorphine,
pubmed-meshheading:8035913-Dose-Response Relationship, Drug,
pubmed-meshheading:8035913-Ferrets,
pubmed-meshheading:8035913-Male,
pubmed-meshheading:8035913-Piperidines,
pubmed-meshheading:8035913-Receptors, Neurokinin-1,
pubmed-meshheading:8035913-Stereoisomerism,
pubmed-meshheading:8035913-Vomiting
|
pubmed:year |
1994
|
pubmed:articleTitle |
Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994.
|
pubmed:affiliation |
Merck, Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, U.K.
|
pubmed:publicationType |
Journal Article
|